Location History:
- Newtown, PA (US) (2004 - 2006)
- Olney, MD (US) (2010)
Company Filing History:
Years Active: 2004-2010
Title: The Innovations of Bradley A Ozenberger
Introduction
Bradley A Ozenberger is a notable inventor based in Newtown, PA, with a significant contribution to the field of biomedical research. He holds a total of four patents, showcasing his innovative approach to addressing complex biological challenges. His work primarily focuses on the modulation of apoptosis and the development of novel proteins related to neurological disorders and cancers.
Latest Patents
Ozenberger's latest patents include groundbreaking inventions such as methods of modulating apoptosis using inhibitors of brain-localized protein kinases homologous to homeodomain-interacting protein kinases. This invention provides isolated protein kinase polypeptides related to novel brain-localized protein kinases, termed HIPK4. It also includes isolated nucleic acid molecules that encode these polypeptides, along with inhibitors and methods related to their use. Another significant patent involves the discovery of novel proteins that bind human β-amyloid peptide, along with the polynucleotides encoding these proteins. This invention offers diagnostic, therapeutic, and screening methods employing the polynucleotides and polypeptides.
Career Highlights
Throughout his career, Ozenberger has worked with prominent companies such as Wyeth and American Home Products Corporation. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.
Collaborations
Ozenberger has collaborated with notable individuals in his field, including Jonathan A Bard and Eileen Marie Kajkowski. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in his area of expertise.
Conclusion
Bradley A Ozenberger's contributions to the field of biomedical research through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of neurological disorders and cancers.